Drug class
Fifth-generation cephalosporin prodrug; broad-spectrum beta-lactam antibacterial
Mechanism of action
Ceftobiprole medocaril is converted to active ceftobiprole, which binds penicillin-binding proteins, including PBP2a in MRSA, and inhibits bacterial cell-wall synthesis.
General use cases
- Treatment of Staphylococcus aureus bloodstream infection (bacteraemia), including right-sided infective endocarditis, caused by methicillin-susceptible or methicillin-resistant isolates in adults
- Treatment of acute bacterial skin and skin-structure infections and community-acquired bacterial pneumonia in eligible patients under the product-specific label; route and age eligibility vary by indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
